Metabolism - Clinical and Experimental
Volume 53, Issue 10 , Pages 1342-1348, October 2004

Induction of the apolipoprotein AI promoter by Sp1 is repressed by saturated fatty acids

  • Michael J. Haas

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St Louis, MO, USA
  • ,
  • Mohamad H. Horani

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St Louis, MO, USA
  • ,
  • Norman C.W. Wong

      Affiliations

    • Division of Endocrinology, University of Calgary, Calgary, Alberta, Canada
  • ,
  • Arshag D. Mooradian

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St Louis, MO, USA
    • Corresponding Author InformationAddress reprint requests to Arshag D. Mooradian, MD, Division of Endocrinology, Saint Louis University, 1402 S Grand Blvd, St Louis, MO 63104 USA

Received 10 January 2004; accepted 21 May 2004.

Abstract 

Insulin induces transcription of the hepatic apolipoprotein AI (apo AI) gene by increasing Sp1 binding to the promoter. To determine the effect of fatty acids on this process, HepG2 cells cotransfected with the plasmid pAI.474.CAT containing the full-length apo AI promoter and the Sp1-expressing plasmid, pCMV-Sp1, were studied. Chloramphenicol acetyl transferase (CAT) activity (% acetylation) increased 1.98-fold in cells receiving the Sp1 expression construct relative to control cells (46.4% ± 0.6% v 23.4% ± 1.3%, P < .05). Treatment of cells with 3 saturated fatty acids, stearic, myristic, and palmitic acid, repressed the ability of exogenous Sp1 to induce apo AI reporter gene expression (15.2% ± 1.7%, 22.5% ± 0.3%, 22.9% ± 0.1%, 23.5% ± 0.8%, respectively, P < .05). Unsaturated fatty acids, oleic, linoleic, or linolenic acid had no effect on Sp1-mediated induction of the apo AI promoter. In the presence of the trans fatty acids, CAT activity in the Sp1-transfected cells was similar to control cells (16.7% ± 3.3%, 19.3% ± 0.5%, and 21.0% ± 2.1% acetylation in cells exposed to elaidic acid, linolelaidic, or linolenelaidic acid, respectively). In cells treated with an equimolar mixture of oleic acid and stearic acid, apo AI promoter activity was suppressed in a manner similar to that observed in stearic acid-treated cells. Insulin (100 μU/mL) induced apo AI promoter activity 2.9-fold (22.4% ± 1.7% v 7.8% ± 2.4%, P < .05). However, in the presence of stearic acid, insulin was unable to induce apo AI promoter (6.3% ± 1.6%). Stearic acid treatment did not alter Sp1-DNA binding as measured by gel shift analysis. Therefore, saturated fatty acids blunt Sp1 induction of apo AI promoter probably at a step beyond DNA binding.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by the Harold Braun Memorial Fund.

PII: S0026-0495(04)00242-2

doi:10.1016/j.metabol.2004.05.011

Metabolism - Clinical and Experimental
Volume 53, Issue 10 , Pages 1342-1348, October 2004